Abstract:

From January 2003 till January 2008 transhepatic endobiliar stenting was performed in 62 patients with obstructive jaundice due to high post-operative malignant strictures of hepaticocholedochus duct. In 49 cases (79 %) two-step intervention performed (biliary drainage followed by endobiliary stenting), 13 patients (21 %) underwent single-stage intervention. In 60 patients (96,8%) balloon dilatation was done prior to stent implantation. In 59 cases (95,2%) the procedure was completed by control drainage placement. Hospital stay for the endobiliary stenting procedure was 12,7-22,3 days (average hospital stay 17,5 days). Mortality was as high as 12,9% (8 cases). Average post-implantation life span appeared to be 9,7 months. In 5 patients (8,1%) mechanical jaundice relapse occurred, so they needed hospitalization for reintervention. Direct dependence found between the effectiveness of endobiliary stenting and the technical characteristics of stents, anatomy of biliary strictures, as well as the methods and techniques of the intervention. Single-stage endobiliary stenting, without prior drainage, decreases the complication rate, improves the quality of life during the hospital stay, and prolongs the post-implantation life expectancy. Single-stege interventions are also shown to decrease the hospital stay and reduce the costs. Balloon dilatation is the required stage of the intervention, especially if self-expandable stents are used in torturous biliary ducts. Post-implantation drainage placement can be skipped if the wall of the hepatico-choledochus duct is not edematous, there are no signs of tumor prolapse into the lumen, if the stent is completely expanded, and the contrast media evacuates easily into the intestine.

Reference

1.     Wiechel К. Percutaneous transhepatic cholangiography: technique and application withstudies of the hepatic venous and biliary ductpressures, the chemical changes in blood andbile and clinical results in a series of jaundicedpatients. Acta Chir Scand Suppl. 1964; 330(11): 1-99.

2.     Fern6ndez-Aguilar J., Santoyo J., Su6rezMuсoz M. et al. Biliary reconstruction in livertransplantation: is a biliary tutor necessary. Cir Esp. 2007; 82 (6): 338-340.

3.     Kasahara M., Egawa H., Takada Y. et al. Biliaryreconstruction in right lobe living-donor livertransplantation: Comparison of differenttechniques in 321 recipients. Annals of Surgery. 2006; 243 (4): 559-566.

4.     Alsharabi A., Zieniewicz K., Patkowski W. et al.Assessment of early biliary complications afterorthotopic liver transplantation and their relationship to the technique of biliary reconstruction. Transplantation proceedings. 2006; 38 (1): 244-246.

5.     Bahra M., Jacob D. Surgical palliation ofadvanced pancreatic cancer. Recent. Results. Cancer. Res. 2008; 177: 111-120.

6.     Das A., Sivak M.J. Endoscopic palliation forinoperable pancreatic cancer. Cancer. Control.2000; 7 (5): 452-457.

7.     Maire E, Hammel P., Ponsot P. et al. Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas. Am J Gastroenterol. 2006; 101 (4):735-742.

8.     Katsinelos P., Paikos D., Kountouras J. et al. Tannenbaum and metal stents in the palliative treatment of malignant distal bile duct obstruction: a comparative study of patency and cost effectiveness. SurgicalEndoscopy. 2006; 20 (10): 1587-1593.

9.     Hatzidakis A., Tsetis D., Chrysou E. et al. Nitinol stents for palliative treatment of malignant obstructive jaundice: Should we stent the sphincter of oddi in every case? Cardiovasc. Intervent. Radiol. 2001; 24: 245-248.

10.   Kaassis M., Boyer J., Dumas R. et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc. 2003; 57: 178-182.

11.   Ikeda S., Maeshiro K. Interventional treat ment of biliary stricture. Nippon. Geka. Gakkai. Zasshi. 2004; 105 (6): 374-379.

12.   Brountzos E., Ptochis N., Panagiotou I. et al. A survival analysis of patients with malignant biliary strictures treated by percutaneous metallic stenting. Cardiovasc. Intervent. Radiol. 2007; 30(1): 66-73.

13.   Nakamura T., Hirai R., Kitagawa M. et al. Treatment of Common Bile Duct Obstruction by Pancreatic Cancer Using Various Stents: Single-Center Experience. Cardiovasc. Intervent. Radiol. 2002; 25: 373-380.

14.   Tesdal I., Roeren T., Weiss С et al. Metallic stents for treatment of benign biliary obstruction: a long-term study comparing different stents. J. Vasc. Interv. Radiol. 2005; 16 (11): 1479-1487.

15.   Oikarinen H., Leinonen S., Karttunen A. et al. Patency and complications of percutaneously inserted metallic stents in malignant biliary obstruction.J. Vasc. Intervent. Radiol. 1999; 10: 1387-1393.

16.   Yoshida H., Taniai N., Mamada Y. et al. One-step palliative treatment method for obstructive jaundice caused by unresectable malignancies by percutaneous transhepatic insertion of an expandable metallic stent. J. World. J. Gastroenterol. 2006; 21; 12 (15): 2423-2426.

17.   Cowling M., Adam A. Internal stenting in malignant biliary obstruction. World. J. Surg. 2001; 25: 355-361.

18.   Isayama H., Komatsu Y., Tsujino T. et al. Polyurethane-covered metal stent for management of distal malignant biliary obstruction. Gastrointest. Endosc. 2002; 55 (3): 366-370.

19.   Yoon W., Lee J., Lee K. et al. A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest. Endosc. 2006; 63 (7): 996-1000.

20.   Chen J., Sun C, Liao C, Chua C. Self-expandable metallic stents for malignant biliary obstruction: efficacy on proximal and distal tumors.J. World. J. Gastroenterol. 2006; 7; 12 (1): 119-122.

21.   Inal M., Aksungur E., Akgьl E. et al. Percutaneous Placement of Metallic Stents in Malignant Biliary Obstruction: One-Stage or Two-Stage Procedure? Pre-Dilate or Not? Cardiovasc. Intervent. Radiol. 2003; 26: 40-45.

Abstract:

The authors report 44 successful implantations of original retrieval Nitinol stent-filters, unique "closed" design of which comprehensively described in the article. All the devices placed for pulmonary embolism (PE) management in patients with lower extremity and pelvic deep vein (DV) thrombosis. Authors announce absolute efficiency of their stent-filters for PE prophylaxis, and the procedure itself declared to be safe and minimally invasive.

Stent-filter implantation into iliac veins compared to standard filter placement in inferior vena cava (IVC) excludes risks of total infrarenal IVC thrombosis - the major complication of such procedures. It is also associated with early DV recanalization, that in sum radically reduces disability rate. Moreover, in case of IVC abnormalities, kinking or external compression stent-filter into iliac position remains the only option for endovascular PE management. All the above can be mentioned as advantages of using stent-filters.

At the same time authors observe that stent-filters quick incorporation into vessel wall prevented endovascular retrieval of the device in quite a number of cases. Persistent PE threat, requiring prolonged antithrombotic therapy under endovascular protection, might also contribute for low retrievability of the device. 

Reference

1.     Ballew K.A., Philbrick J.T., Becker D.M. Vena cava filters devices. Clin. Chest. Med. 1995; 16: 295-305.

2.     Becker D.M., Philbrick J.T., Selby J.B. Inferior vena cavafilters. Indications, safety, effectiveness. Arch. Intern. Med.1992; 152 (10): 1985-1994.

3.     Streiff M.B. Vena caval filters: a comprehensive review.Blood. 2000; 95: 3669-3677.

4.     Ferris E.J., McCowanT.C., Carver D.K., McFarland D.R.Percutaneous inferior vena caval filters: Follow-up ofseven designs in 320 patients. Radiology. 1993; 188:851-856.

5.     Mismetti P., Rivron-Guillot K., Quenet S., D cousus H.,Laporte S., Epinat M., Barral, F.G. A рrospective long-term study of 220 patients with a retrievable vena cava-filter for secondary hrevention of venous thromboembolism. Chest. 2007; 131:223-229.

6.     Rosenthal D., Wellons E.D., Lai K.M., Bikk A., Henderson V.J. Retrievable Inferior vena cava-filters: initial clinical results. Ann. Vasc. Surg. 2006; 20: 157-165.

7.     Asch M.R. Initial experience in humans with a new retrievable inferior vena cava filter. Radiology. 2002; 225:835-844.

8.     Binkert C.A., Sasadeusz K., Stavropoulos S.W. Retrievability of the recovery vena cava-filter after dwell times longer than 180 days. J. Vasc. Interv. Radiol. 2006;17: 299-302.

9.     De Gregorio M.A. et al. Retrieval of g nther tulip optional vena cava-filters 30 days after Implantation: Aprospective clinical study. J. Vasc. Interv. Radiol. 2006;17: 1781-1789.

10.   Oliva V.L., Szatmari F.et al. The jonas study: evaluationof the retrievability of the cordis optease inferio venacava-filter./ Vase. Interv. Radiol. 2005; 16: 1439-1445.

11.   Guglielmo ЕЕ, Kurtz A.B., Wechsler R.J. Prospectivecomparison of computed tomography and duplex sonography in the evaluation of recently inserted Kim-ray - Greenfield filters into the inferior vena cava. Clin.Imaging. 1990; 14:216-220.

12.   Kinney T.B., Rose S.C., Weingarten K.W. et al. IVC filter tilt and asymmetry: comparison of the the over-the-wire stainless-steel and titanium Greenfield IVC filters.J. Vasc. Interv. Radiol. 1997; 8: 1080-1082.

13.   Kinney T.B., Rose S.C. Regarding «limb asymmetry intitanium Greenfield filters».J. Vasc. Surg. 1998; 16:436-444.

14.   Прокубовский В.И., Капранов С.А., Савельев В.С.,Балан А.Н., Защеринская Н.А., Ломков С.С., Никитина А.В., Поликарпов О.В., Поликарпов И.В.Внутрисосудистый стент-фильтр. Патент РФ№ 2143246, приоритет от 03.06.99 г.

15.   Капранов С.А., Кузнецова В.Ф., Златовратский А.Г. Удаляемый стент-фильтр для профилактики тромбоэмболии легочной артерии. Международный журнал интервенционной кардиоангиологии. 2005; 7: 44.

16.   Кузнецова В.Ф., Капранов С.А., Златовратский А.Г. Применение стента-фильтра в эндоваскулярной профилактике тромбоэмболии легочной артерии. В сб. Новые технологии в хирургии. Ростов-на Дону.2005; 297.

17.   Прокубовский В.И., Капранов С.А. Эндоваскулярные вмешательства при тромбозе и эмболии. В кн.Флебология (руководство для врачей). Под ред. акад.В.С. Савельева. М.: Медицина, 2001; 351-390.

18.   Grams J., The S.H., Torres V.E.,. Andrews J.C. Nagor-ney D.M. Inferior vena cava-stenting: A safe and tffec-tive treatment for intractable ascites in patients with polycystic liver disease.J. Gastrointest. Surg. 2007; 11:985-990.

19.   Kishi K., SonomuraT., Fujimoto H., Kimura M., Yamada K., Sato M., Juri M. Physiologic tffect of stent therapy for Inferior vena cavajbstruction due to valignant liver tumor. Cardiovasc. Intervent. Radiol. 2006; 29: 75-83.

20.   Heijmen R., Bollen T., Duyndam D. et al. Endovascular venous stenting in May-Thurner syndrome.J. Cardiovasc. Surg. 2001; 42 (1): 83-87.

21.   Прокубовский В.И., Капранов С.А., МоскаленкоЕ.П. Анатомические и гемодинамические изменения нижней полой вены при профилактике тромбоэмболии легочной артерии. Ангиология и сосудистая хирургия. 2003; 2 (9): 51-60.

22.   Marcy P., Magne N., Frenay M. et al. Renal failure secondary to thrombotic complications of suprarenal inferior vena cava filter in cancer patients. Cardiovasc. Intervent. Radiol. 2001; 24: 257-259.

Abstract:

By authors it is resulted results of application of system for Angojet rheolytic trombectomy in treatment of acute thromboses of the main veins and pulmonary embolism. On the basis of the data received with use rheolytic trombectomy in system vena cava superior and vena cava inferior and pulmonaty artery thrombosis? Authors conclude, that system Jet-9000 is a modern and highly effective method of treatment of venous tromboses of varios localisation and their complications. Authors specify? That tactic of the use of this method can provide as its isolated, and conjaction application with trombolytic therapy, ballon angyoplasty, stenting and others endovascular techniques. Besides rheolytic trombectomy is an alternative at existence contraindications for standard methods of treatment acute venouse thromboses. At the same time, authors emphasize, that in some cases rheolytic thrombectomy can be main method of treatment of patients with venous patology, before considered incurable (a thrombosis vena cava inferior after cavafilter-implantation, massive pulmonary artery thrombosis).

Reference 

1.     Persson А.V, Davis R J., Villavicencio J.L. Deep venous thrombosis and pulmonary embolism. Surg. Clin. North Am. 1991; 71: 1195-1209.

2.     O'Donnell T.F., Browse N.L., Burnard K.G., Thomas M.L. The socioeconomic effects of an iliofemoral thrombosis./ Surg. Res. 1977; 22: 483-488.

3.     Plate G., Ohlin P., Eklof B. Pulmonary embolism in the acute iliofemoral venous thrombosis. Br. J. Surg. 1985; 72:912-915.

4.     Robinson D.L.,Teitelbaum G.P. Phlegmasia cerulea dolens: reatment by pulse-spray and infusion thrombolysis. Am.]. Roentgenol. 1993; 160: 1288-1290.

5.     Weaver F.A., Meacham P.W., Adkins R.B., Dean R.H. Phlegmasia cerulea dolens: therapeutic considerations. South. Med.J. 1988; 81: 306-312.

6.     Linder D.J., Edwards J.M., Phinney E.S. et al. Long-term hemodynamic and clinical sequelae of lower extremity deep vein thrombosis. / Vase. Surg. 1986; 4: 436-442.

7.     Kasirajan K., Gray В., Ouriel K. Percutaneous angiojet thrombectomy in the management of extensive deep venous thrombosis./ Vase. Interv. Radiol. 2001;12: 179-185.

8.     Hyun S., Kim M.D. et al. Adjunctive percutaneous mechanical thrombectomy for lower extremity deep vein thrombosis: clinical and economic outcomes. / Vase. Interv. Radiol. 2006; 17: 1099-1104.

9.     Becker G., Holden R., Rabe F. et al. Local thrombolytic therapy for subclavian and axillary vein thrombosis: treatment of thoracic inlet syndrome. Radiology. 1983; 149: 419-423.

10.   Beygui R., Olcott C., Dlaman R. Subclavian vein thrombosis: outcome analysis based on ethiology and modality of treatment. Ann. Vase. Surg. 1997; 11: 247-255.

11.   A consensus document. Thrombolysis in the management of lower limb peripheral arterial occlusion / Vase Interv. Radiol 2003; 14: 337-349.

12.   Watson L., Armon M. Thrombolysis for acute deepvein thrombosis. Cochrane Database Syst. Rev. 2004; CD 002783.

13.   Савельев B.C. Роль хирурга в профилактике и лечении венозного тромбоза и легочной эмболии. В кн.: 50 лекций по хирургии. Под ред. B.C. Савельева. М.: Media Medica. 2003; 92-99.

14.   Кривинш Д.К., Бейгай Р.Е., Катлапс Г.Дж., Фогарти Т.Дж. Какова роль тромбэктомии при тромбозах полой вены и илеофеморального сегмента? Ангиология и сосудистая хирургия. 1997; 1: 83-97.

15.   Кириенко А.И., Матюшенко А.А., Андрияшкин В.В. Тромбоз в системе нижней полой вены. В кн.: Флебология (руководство ДЛЯ врачей). Под ред. акад. B.C. Савельева. М.: Медицина. 2001; 208-279.

16.   May R., Thurner J. Ein gefassporn in der vena iliacacommunis sinistra als wahrscheinliche ursache deruberwiegende linksseitigen beckenvenenthrombose. Z. Kreisl-Forsch. 1956; 45: 912-922.

17.   Baron H.C., Sharms J., Wayne M. Iliac vein compression syndrome: A new method of treatment. Am. Surg. 2000; 66: 653-655.

18.   Burroughs K.E. New considerations in the diagnosis and therapy of deep vein thrombosis. South. Med. J. 1999; 92: 517-520.

19.   O'Donnell T.E, Browse N.L., Burnand K.G., Thomas M.L. The socioeconomic effects of iliofemoral throm bosis./ Surg. Res. 1987; 22: 483-488.

20.   Patel N.H., Stookey K.R., Ketcham D.B., Cragg A.H. Endovascular management of acute extensive iliofemoral deep venous thrombosis caused by May-Thurner syndrome./ Vase. Interv. Radwl. 2000; 11: 1297-1302.

21.   Thomas В., Kinney M.D. Update on inferior vena cava-filters./ Vase. Interv. Radiol. 2003; 14: 425-440.

22.   Becker D.M. Inferior vena cava-filters: Indication, so-fety effectivness. Arch. Intern. Med. 1992; 152: 1985-1994.

23.   Kaufman J.A., Kinney ТВ. et al. Guidelines for the use of retrievable and convertible vena cava-filters. Report from the society of Interventional radiology multidisciplinary consensus conference. / Vase. Interv. Radiol. 2006; 17: 449-459.

24.   Златовратский А.Г., Капранов С.А. Анализ причин развития тромботических окклюзии нижней полой вены после имплантации кава-фильтров. В кн.: Новые технологии в хирургии. Ростов-на Дону. 2005;281-282.

25.   Rahimtoola A., Bergun J.D. Acute pulmonary embolism: an update on diagnosis and management. Curr. Probl. Cardiol. 2005; 30: 61-114.

26.   Sharafuddin M., Hicks M. Current status of percutaneous mechanical thrombectomy. Part I. General principles./ Vase. Interv. Radiol. 1997; 8: 911-921.

27.   Sharafuddin M., Hicks M. Current status of percutaneous mechanical thrombectomy. Part II. Devices and mechanisms of action. J. Vase. Interv. Radiol. 1998; 9: 15-31.

28.   Fava M., Loyola S., Flores P. et al. Mechanical frag mentation and pharmacologic thrombolysis in massive pulmonary embolism. / Vase. Interv. Radiol. 1997; 8: 261-266.

29.   Greenfield L., Proctor M., Williams D. et al. Long-term experience with transvenous catheter pulmonary embolectomy. / Vase. Interv. Radiol. 1993; 18: 450-458.

30.   Michalis L., Tsetis D., Rees M. Case report: percuta neous removal of pulmonary artery thrombus in a patient with massive pulmonary embolism using the Hydrolyser catheter: the first human experience. Clin.Radiol. 1997; 52: 158-161.

31.   Voigtlander Т., Rupprecht H., Nowak B. et al. Clinical application of a new rheolytic thrombectomy catheter system for massive pulmonary embolism. Catheter Cardiovasc. Interv. 1999; 47: 91-96.

32.   Schmitz-Rode T, Tanssens U., Schild H. et al. Framentation of massive pulmonary embolism using pigtail rotation catheter. Chest. 1998; 114: 1427-1436.

33.   Rocek M., Peregrin J., Velimsky T Mechanical thrombectomy of massive pulmonary embolism using an Arrow-Trerotola percutaneous thrombolytic device. Eur. Radiol. 1998; 8: 1683-1685.

34.   Uflacker R., Strange C, Vujic I. Massive pulmonary embolism. Preliminary results of treatment with the Amplatz thrombectomy device. / Vase. Interv. Radiol. 1996; 7: 519-528.

35.   Schmitt H.-E., Jager K., Jacob A. et al. A new rotational thrombectomy catheter: system design and first clinical experiences. Cardiovasc. Interv. Radiol. 1999; 22: 504-509.

36.   Капранов С.А., Бобров Б.Ю. Эндоваскулярная роторная дезобструкция при массивной эмболии легочных артерий. В кн.: 1-й Российский съезд интервенционных кардиоангиологов. М. 2002; 12.

Abstract:

Department of Obstetrics and Gynaecology of the Therapeutic and Moscow Faculties of Scientific Research Practical Laboratory of intracardiac and contrast methods of roentgenological studies under the Federal Facility Russian State Medical University of the Russian Ministry of Public Health, Moscow.

This article opens a new series of publications dedicated to a currently important issue of endovascular treatment of uterine myoma - uterine artery embolization (UAE). The authors presently possessing the most abundant hands-on experience in UAE in Russia, based on own experience and literature data discuss herein the most urgent problems related to UAE in treatment for uterine myoma and other obstetrical and gynaecological pathology. Amongst them are the problems of determining the indications for and contraindications to an intervention, outcomes of UAE (including that combined with other therapeutic methods), problems of optimization of the technique and development of technical procedures allowing for UAE to be performed virtually in any situation, as well as the problems related to selection of embolizing substances. The authors also give a detailed consideration to the so-called "myths" about UAE - currently existing negative views on certain aspects of intervention, which are based on outdated and inexact evidence. The authors draw a conclusion that endovascular methods are highly promising in obstetrical and gynaecological pathology.

References

1.     Oliver J. A. Jr, Lance J.S. Selective embolization to control massive hemorrhage following pelvic surgery. Am. J. Obstet. Gynecol. 1979; 135: 431-432.

2.     Ravina J., Merland J., Herbreteau D. et al. Preoperative embolization of uterine fibroma. Preliminary results [10 cases] [letter, in French]. Presse Med. 1994; 23: 1540.

3.     Goodwin S., McLucas B., Lee M. et al. Uterine artery embolization for the treatment of uterine leiomyomata midterm results. J. Vasc. Intervent. Radiol. 1999; 10: 1159-1165.

4.     Goodwin S., Vedantham S., McLucas B. et al. Preliminary experience with uterine artery embolization foruterine fibroids. J. Vasc. Interv. Radiol. 1997; 8: 517-526.

5.     Spies J., Scialli A., Jha R. et al. Initial results from uterine fibroid embolization for symptomatic leiomyomata.J.Vasc.Intervent.Radiol. 1999; 10: 1149-1157.

6.     Uterine Artery Embolization Survey: 10,500 Procedures Performed Worldwide, Fairfax, VA: Society ofInterventional Radiology. 2000.

7.     Hovsepian D., Siskin G., Bonn J. et al. Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata. J. Vasc. Interv. Radiol. 2004; 15: 535-542.

8.     Wong G.C., Muir S.J., Lai A.P., Goodwin S.C. Uterine artery embolization: a minimally invasive technique for the treatment of uterine fibroids. J. Womens Health Gend. Based Med. 2000; 4(9): 357-362.

9.     Савельева Г.М., Бреусенко В.Г., Капранов С.А., Краснова И.А., Бобров Б.Ю., Шевченко Н.А., Аксенова В.Б., Алиева А.А. Эмболизация маточных артерий у больных с миомой матки. Акушерство и гинекология. 2004; 5: 21-24.

10.   Worthington-Kirsch R. Uterine artery embolization: state-of-the-art and new developments. Intervention. 2000; 2(4): 35-38.

11.   Beinfeld M.T., Bosch J.L., Isaacson K.B., Gazelle G.S. Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids. Radiology. 2004; 1(230): 207-213.

12.   Al-Fozan H., Dufort J., Kaplow M. et al. Cost analysis of myomectomy, hysterectomy and uterine artery embolization. Am. J. Obstet. Gynecol. 2002; 5(187): 1401-1404.

13.   Капранов С.А., Беленький А.С., Бобров Б.Ю., Доброхотова Ю.Э., Журавлева А.Д., Алиева А.А., Кайфаджан М.М. Эмболизация маточных артерий в лечении миомы матки: 126 наблюдений. Бюллетень НЦ ССХ им. А.Н. Бакулева РАМН «Сердечно-сосудистые заболевания». 2003; 11(4): 219.

14.   Тихомиров А.Л., Лубнин Д.М. Эмболизация маточных артерий в лечении миомы матки. Вопросы гинекологии, акушерства и перинатологии. 2002; 2(1): 83-85.

15.   Билан М.И., Козюра О.П. Эмболизация маточных артерий при миоме матки: особенности катетеризационной техники. Международный журнал интервенционной кардиоангиологии. 2004; 4: 43-46.

16.   Кавтеладзе З.А., Дроздов С.А., Былов К.В. и др. Эмболизация маточных артерий при фибромиоме матки. Международный журнал интервенционной кардиоангиологии. 2005; 7: 55.

17.   Бреусенко В.Г., Краснова И.А., Капранов С.А., Бобров Б.Ю., Аксенова В.Б., Шевченко Н.А., Арютин Д.Г. Некоторые дискуссионные вопросы эмболизации маточных артерий при лечении миомы матки. Акушерство и гинекология. 2006; 3: 23-26.

18.   Коков Л.С., Самойлова Т.Е., Ситкин И.И., Цыганков В.Н., Гус А.И. Динамика редукции миоматозных узлов в зависимости от их локализации у пациенток, перенесших эмболизацию маточных артерий по поводу миомы матки. Материалы конференции «Радиология 2006» 25-27 апреля 2006; 235.

19.   Lohle P.N.M., Lapmann L., Boekkooi F.P., Vervest H.A.M. Specialists collaborate in fibroid treatment. Diagnostic Imaging Europe. 2002; 23-25.

20.   David M., Ebert A.D. Treatment of uterine fibroids by embolization - advantages, disadvantages, and pitfalls. Eur. J.Obstet. Gynecol. Reprod Biol. 2005; 2(122): 144-150.

21.   Nikolic B., Spies J.B., Campbell L. et al. Uterine artery embolization: Reduced radiation with refined technique. J. Vasc. Intervent. Radiol. 2001; (12): 39-44.

22.   Brunereau L., Herbreteau D., Gallas S. et al. Uterine artery embolization in the primary treatment of uterine leiomyomas: technical features and prospective follow-up with clinical and sonographic examinations in 58 patients. AJR. 2000; 175: 1267-1272.

23.   Pelage J., Le Dref O., Soyer P. et al. Arterial anatomy of the female genital tract: Variations and relevance to transcatheter embolization of the uterus. AJR. 1999; 172: 989-994.

24.   Katsumori T., Nakajima K., Mihara T., Tokuhiro M. Uterine artery embolization using gelatin sponge particles alone for symptomatic uterine fibroids: Midterm results. AJR. 2002; 178: 135-139.

25.   Du J., Zuo Y., Chen X. et al. Clinical observation of transcatheter uterine artery embolization for uterine myoma. Zhonghua Fu Chan Ke Za Zhi. 2002; 1(37): 12-15.

26.   Belenky A., Cohen M., Bachar G. Uterine arterial embolization for the management of leiomyomas. Isr. Med.Assoc.J. 2001; 10(3): 719-721.

27.   Доброхотова Ю.Э., Капранов С.А., Бобров Б.Ю., Алиева А.А., Гришин И.И. Эмболизация маточных артерий - постэмболизационный синдром. Российский вестник акушера-гинеколога. 2005; 2(5): 44-49.

28.Nagao T., Ohwada T., Kitazono M., Ohshima K., Shimizu H., Katayama M. Thoracic epidural analgesia is effective in perioperative pain relief for uterine artery embolization. Masui. 2005; 2(54): 156-159.

29.   Saito S., Chiba A., Hayakawa S.,Toyoshima M., Enomoto A. Pain control with epidural anesthesia for uterine artery embolization. Masui. 2004; 4(53): 391-395.

30.   Ryan J.M., Gainey M., Glasson J., DohertyJ., Smith T.P. Simplified pain-control protocol after uterine artery embolization. Radiology. 2002; 2(224): 610-611, discussion 611-613.

31.   Rasuli P., Jolly E.E., Hammond I., French G.J., Preston R., Goulet S., Hamilton L., Tabib M. Superior hypogastric nerve block for pain control in outpatient uterine artery embolization. J. Vasc. Interv. Radiol. 2004; 12(15): 1423-1429.

32.   Keyoung J.A., Levy E.B., Roth A.R. et al. Intraarterial lidocaine for pain control after uterine artery embolization for leiomyomata. J. Vasc. Interv. Radiol 2001; 9(12): 1065-1069.

33.   Капранов С.А., Бреусенко В.Г., Бобров Б.Ю., Краснова И.А., Шевченко Н.А., Алиева А.А., Аксенова В.Б. Применение эмболизации маточных артерий при лечении миомы матки: анализ 258 наблюдений. Международный журнал интервенционной кардиоангиологии. 2005; 7: 56.

34.   Walker W.J., Pelage J.P. Uterine fibroid embolization: Results in 400 women with imaging follow-up. J. Vasc. Interv. Radiol. 2002; 13 (Suppl. 2): 18.

35.   Доброхотова Ю.Э., Капранов С.А., Алиева А.А., Бобров Б.Ю., Гришин И.И. Новый органосохраняющий метод лечения миомы матки — эмболизация маточных артерий. Лечебное дело. 2005; 2: 24—27. 36.Jha R.C., Ascher S.M., Imaoka I., Spies J.B. Symptomatic fibroleiomyomata: MR imaging of the uterus before and after uterine arterial embolization. Radiology. 2000; (217): 228-235.

37.   Бреусенко В.Г., Краснова И.А., Капранов С.А., Аксенова В.Б., Бобров Б.Ю., Шевченко Н.А. Спорные вопросы эмболизации маточных артерий при миоме матки. Вопросы гинекологии, акушерства и перинатологии. 2005; 4(4): 44—48.

38.   Kim M.D., Kim N.K., Kim H.J., Lee M.H. Pregnancy following uterine artery embolization with polyvinylalcohol particles for patients with uterine fibroid or adenomyosis. Cardiovasc. Intervent. Radiol. 2005; 5(28): 611-615.

39.   D'Angelo A., Amso N.N., Wood A. Spontaneous multiple pregnancy after uterine artery embolization for uterine fibroid: case report. Eur. J. Obstet. Gynecol. Reprod. Biol. 2003; 2(110): 245-246.

40.   Nabeshima H., Murakami T., Sato Y., Terada Y., Yaegashi N., Okamura K. Successful pregnancy after myomectomy using preoperative adjuvant uterine artery embolization. Tohoku J. Exp. Med. 2003; 3(200): 145-149.

41.   Carpenter T.T., Walker W.J. Pregnancy following uterine artery embolisation for symptomatic fibroids: a series of 26 completed pregnancies. BJOG. 2005; 3(112): 321-325.

42.   Price N., Gillmer M.D., Stock A., Hurley P.A. Pregnancy following uterine artery embolisation. J. Obstet. Gynaecol. 2005; 1(25): 28-31.

43.   Stringer N.H., Grant T., Park J., Oldham L. Ovarian failure after uterine artery embolization for treatment of myomas. J. Am. Assoc. Gynecol. Laparosc. 2000; 3(7): 395-400.

44.   Hascalik S., Celik O., Sarac K., Hascalik M. Transient ovarian failure: a rare complication of uterine fibroid embolization. Acta Obstet. Gynecol. Scand. 2004; 7(83): 682-685.

45.   Payne J.F., Robboy S.J., Haney A.F. Embolic microspheres within ovarian arterial vasculature after uterine artery embolization. Obstet. Gynecol. 2002; 5(100): 883-886.

46.   Healey S., Buzaglo K., Seti L., Valenti D., Tulandi T. Ovarian function after uterine artery embolization and hysterectomy. J. Am. Assoc. Gynecol. Laparosc. 2004; 3(11): 348-352.

47.   Tropeano G., Di Stasi C., Litwicka K., Romano D., Draisci G., Mancuso S. Uterine artery embolization for fibroids does not have adverse effects on ovarian reserve in regularly cycling women younger than 40 years. Fertil. Steril. 2004; 4(81): 1055-1061.

48.   Ahmad A., Qadan L., Hassan N., Najarian K. Uterine artery embolization treatment of uterine fibroids: effect on ovarian function in younger women. J. Vasc. Interv. Radiol. 2002; 10(13): 1017-1020.

49.   Pelage J.P., Walker W.J., Le Dref O., Rymer R. Ovarian artery: angiographic appearance, embolization and relevance to uterine fibroid embolization. Cardiovasc. Intervent. Radiol. 2003; 3(26): 227-233.

50.   Barth M.M., Spies J.B. Ovarian artery embolization supplementing uterine embolization for leiomyomata. J. Vasc. Interv. Radiol. 2003; 9(14): 1177-1182.

51.   Andrews R.T., Bromley P.J., Pfister M.E. Successful embolization of collaterals from the ovarian artery during uterine artery embolization for fibroids: a case report. J. Vasc. Interv. Radiol. 2000; 5(11): 607-610.

52.   YangJ.J., Xiang Y., Wan X.R., Yang X.Y Diagnosis and management of uterine arteriovenous fistulas with massive vaginal bleeding. Int. J. Gynaecol. Obstet. 2005; 2(89): 114-119. 53.Rubod C., Mubiayi N., Robert Y., Vinatier D. Uterine arteriovenous malformation. A rare cause of recurrent metrorrhagia. Gynecol. Obstet. Fertil. 2005; 7-8(33): 511-513.

54.   Lipari C.W., Badawy S.Z. Arteriovenous malformation in a bicornuate uterus leading to recurrent severe uterine bleeding: a case report. J. Reprod. Med. 2005; 1(50): 57-60.

55.   Amagada J.O., Karanjgaokar V, Wood A., Wiener J.J. Successful pregnancy following two uterine artery embolisation procedures for arteriovenous malforma tion. J. Obstet. Gynaecol. 2004; 1(24): 86-87.

56.   Lambert P., Marpeau L., Jan net D. et al. Cervical pregnancy: conservative treatment with primary embolization of the uterine arteries. A case report. Review of the literature. J. Gynecol. Obstet. Biol. Reprod. 1995; 1(24): 43-47.

57.   Suzumori N., Katano K., Sato T. et al. Conservative treatment by angiographic artery embolization of an 11-week cervical pregnancy after a period of heavy bleeding. Fertil. Steril. 2003; 3(80): 617-619.

58.   Sherer D.M., Lysikiewicz A., Abulafia O. Viable cervical pregnancy managed with systemic Methotrexate, uterine artery embolization, and local tamponade with inflated Foley catheter balloon. Am. J. Perinatol. 2003; 5(20): 263-267.

59.   Itakura A., Okamura M., Ohta T., Mizutani S. Conservative treatment of a second trimester cervicoisthmic pregnancy diagnosed by magnetic resonance imaging. Obstet. Gynecol. 2003; 5(101): 1149-1151.

60.   Hong T.M., Tseng H.S., Lee R.C., Wang J.H., Chang C.Y Uterine artery embolization: an effective treat ment for intractable obstetric haemorrhage. Clin. Radiol. 2004; 1(59): 96-101.

61.   Liu X., Fan G., Jin Z., Yang N., Jiang Y., Gai M., Guo L., Wang Y., Lang J. Lower uterine segment pregnancy with placenta increta complicating first trimester induced abortion: diagnosis and conservative management. Chin. Med. J. 2003; 5(116): 695-698.

62.Sugawara J., Senoo M., Chisaka H., Yaegashi N., Okamura K. Successful conservative treatment of a cesarean scar pregnancy with uterine artery embolization. Tohoku J. Exp. Med. 2005; 3(206): 261-265.

63.   Kapranov S.A., Kurtser M.A., Bobrov B.Y., Alieva A.A., Zlatovratsky A.G. Non-fibroid indications for UAE: twelve cases. CIRSE 2006: 244.

Abstract:

The minute methodical details and technical aspects of uterine arteries embolization, crucial for successful intervention, are reviewed in this article. The text provides detailed descriptions of roentgen anatomy of the internal iliac arteries, different variants of blood circulation in uterus and ovaries and various types of anastomozes between uterine and ovarian arteries. The techniques indispensable for successful embolization of uterine arteries in complex anatomic cases and in peculiar ways of uterine arteries formation are thoroughly described.

References

1.     Pelage J., Le Dref О., Soyer P. et al. Arterial anatomy of the female genital tract: variations and relevance to transcatheter embolization of the uterus, AJR. 1999; 172: 989 - 994.

2.     Nikolic В., Spies J., Campbell L. et al. Uterine artery embolization: reduced radiation with refined technique,/ Vase. Intervent. Radiol. 2001; 12: 39 - 44.

3.     Капранов С.А., Бреусенко В.Г., Бобров Б.Ю. и соавт. Применение эмболизации маточных артерий при лечении миомы матки: анализ 258 наблюдений. Международный журнал интервенционной кардиоангиологии. 2005; 7: 56.

4.     Stringer N., Grant Т., Park J., Oldham L. Ovarian failure after uterine artery embolization for treatment of myomas./. Am. Ass. Gynecol. Laparose. 2000; 7(3): 395 - 400.

5.     Payne J., Robboy S., Haney A. Embolic microspheres within ovarian arterial vasculature after uterine artery embolization. Obstet. Gynecol. 2002; 100 (5): 883 - 886.

6.     Barth M., Spies J. Ovarian artery embolization supple-meriting uterine embolization for leiomyomata. J. Vase. Interv. Radiol. 2003; 14 (9): 1177-1182. 7. Pelage J., Walker W, Le Dref O., Rymer R. Ovarian artery: angiographic appearance, embolization and relevance to uterine fibroid embolization. Cardiovasc. Interv. Radiol 2003; 26(3): 227-233.